Loading market dashboard
Direxion Daily MSCI South Korea Bull 3X ETF
KORUFinancial ServicesAMEXUS
Loading disclosure news
News and disclosures filtered by period, publisher, and event group.
Select a headline to open the full news page in the app.
If you owned Direxion Daily MSCI South Korea Bull 3X Shares (NYSEARCA:KORU) into the close on Friday, June 5, 2026, you watched $10,000 turn into roughly $5,811 in a single session, and you watched a $1,050 share close at $610.
South Korea's AI-fueled rally has made it the world's sixth-largest stock market, and the rally may be far from over. Investors may want to keep South Korea ETFs on their radar.
In previous decades, South Korea has always been a cultural and financial afterthought after Japan, with its dominance in electronics and engineering through companies like Sony, Toyota, JVC, Honda, and Mitsubishi; and China, with its enormous low cost manufacturing, geopolitical and military clout, and expanding middle class prosperity.
Korea has gone mad for AI. Capital-M Mad, the kind that turns a niche 3x leveraged country fund into the most-watched ticker on Korean retail brokerage screens.
South Korea's KOSPI has gone from emerging-markets afterthought to the best major equity story of 2026, and the engine is sitting inside every advanced AI server on Earth.
The Direxion Daily MSCI South Korea Bull 3X Shares (NYSEARCA:KORU) is up roughly 274% year to date and a stomach-churning 1,500% over the past twelve months, which is a chart that pulls retail money out of money market funds and into a product most of those buyers do not understand.
Investors are focusing on AI developments in North Asia. China is coming out of more than three years of deflation measured by the producer price index.
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company presented its latest research at the Oncology Nursing Society (ONS) Congress, May 13-17. The poster at ONS was titled, “Reducing Ergonomic Strain During Subcutaneous Monoclonal Antibody Administration.” The ONS abstract evaluated nur.
The South Korean equity market is now heavily concentrated, with Samsung and SK Hynix comprising a large chunk of overall assets. Korea-based funds are behaving increasing like tech/semiconductor ETFs with mounting sector-specific risk. I see 3x leverage as particularly unsuitable for South Korean stocks given the risk of massive volatility in the asset's top holdings.
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Artificial intelligence (AI) and the word bottleneck have long been joined at the hip. First, it was the race, still ongoing, for compute power.
South Korea's KOSPI delivered one of the strongest runs among major equity markets over the past year, yet almost no one outside Asia noticed because the news cycle was consumed by a war in the Middle East.
MAHWAH, NJ--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that the Company will report first quarter 2026 financial results on Wednesday, May 6, 2026. KORU Medical's management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the.
Top Performing Leveraged/Inverse ETFs Last Week These were last week's top performing leveraged and inverse ETFs. Note that because of leverage, these kinds of funds can move quickly.
Today's market uncertainty demands high-conviction trading. With the month of March coming to a close, the latest Direxion leveraged ETF fund flow data reveals a preference for semiconductors, international recovery, and specific high-growth mega-caps.
KRMD secures EU MDR certification for its Freedom60 Infusion Pump, opening broader EU access and boosting adoption of patient-friendly home infusion solutions.
Direxion Daily MSCI South Korea Bull 3x Shares (NYSEARCA:KORU - Get Free Report) was the target of a large increase in short interest in February. As of February 27th, there was short interest totaling 150,347 shares, an increase of 123.4% from the February 12th total of 67,302 shares. Currently, 11.3% of the company's stock are
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that its Freedom60® Infusion Pump, including adapter for use with 50 mL prefilled syringes, has achieved certification under the European Union Medical Devices Regulation (EU MDR 2017/745), ena.
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that following five years of service to the Company, Linda Tharby, President and Chief Executive Officer, will retire effective June 30, 2026. The Board of Directors has appointed Adam Kalberma.
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today reported financial results for the fourth quarter and full year ended December 31, 2025. The Company also initiated guidance for the full year 2026. Recent Highlights Fourth quarter 2025 net revenues gre.
Volatility continues to rain down on the markets, but there are some shining stars in the bullish leveraged ETF arena. One particular standout is the Direxion Daily South Korea Bull 3X Shares (KORU), which is up over 100% for the year and nearly 400% within the past six months.
